-
平臺編號：bio-68744
-
國際編號：HB-246?
-
細胞信息： 26ic
-
規(guī)格：frozen
-
用途：ATCC原裝細胞
-
服務費用：
加載中…… - 訂購
-
注意事項：僅用于科學研究或者工業(yè)應用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
26ic
是否是腫瘤細胞：0
物種來源：小鼠
ATCC Number：HB-246?
數(shù)量：大量
運輸方式：凍存運輸
生長狀態(tài)：懸浮生長
細胞形態(tài)：淋巴樣
免疫類型：IgG2b; kappa light chain
規(guī)格：10mg Designations: 26ic
Depositors: ?RF Todd
Isotype: IgG2b; kappa light chain
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against human CD14
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with cultured human peripheral blood monocytes.
Spleen cells were fused with NS-1 myeloma cells.
The antibody reacts with a nonfunctional domain of human CD14.
The binding of 26ic does not inhibit CD14 mediated activities, and is useful for detecting CD14 expression by immunofluorescence and or immunocytochemical methods.
Propagation: ATCC complete growth medium: Modified Dulbecco's medium, 90%; heat-inactivated gamma globulin free horse serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 46-X
References: 22487: Todd RF, et al. Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma 1: 329-337, 1982. PubMed: 6208133
23506: Wright SD, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433, 1990. PubMed: 1698311
物種來源：小鼠
ATCC Number：HB-246?
數(shù)量：大量
運輸方式：凍存運輸
生長狀態(tài)：懸浮生長
細胞形態(tài)：淋巴樣
免疫類型：IgG2b; kappa light chain
規(guī)格：10mg Designations: 26ic
Depositors: ?RF Todd
Isotype: IgG2b; kappa light chain
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against human CD14
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with cultured human peripheral blood monocytes.
Spleen cells were fused with NS-1 myeloma cells.
The antibody reacts with a nonfunctional domain of human CD14.
The binding of 26ic does not inhibit CD14 mediated activities, and is useful for detecting CD14 expression by immunofluorescence and or immunocytochemical methods.
Propagation: ATCC complete growth medium: Modified Dulbecco's medium, 90%; heat-inactivated gamma globulin free horse serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 46-X
References: 22487: Todd RF, et al. Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma 1: 329-337, 1982. PubMed: 6208133
23506: Wright SD, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433, 1990. PubMed: 1698311
